Efficacy of Mesalazine Combined With Biologics in the Treatment of Moderate to Severe Ulcerative Colitis

NCT05205603 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

438

Enrollment

OTHER

Sponsor class

Conditions

Ulcerative Colitis
Efficacy, Self
Biologics
Mesalazine

Interventions

DRUG: Infliximab
DRUG: Vedolizumab
DRUG: Mesalazine

Sponsor

Sixth Affiliated Hospital, Sun Yat-sen University